Kaiser Permanente Center for Thoracic Aortic Disease study confirms low long-term risk for most aneurysms OAKLAND, Calif., Oct. 5, 2022 /PRNewswire/ — A large, new Kaiser Permanente study provides high-quality evidence that most of the 33,000 patients diagnosed each year in the U.S. with a thoracic aortic aneurysm — a bulge in […]
Other News
VentureMed Announces First Patient Treated With The FLEX Vessel Prep™ System AV Focused 75cm Product
MINNEAPOLIS, Oct. 5, 2022 /PRNewswire/ — VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that Dr. Ari Kramer, Assistant Professor, Department of Surgery and Director, Vascular Access Program, Spartanburg Regional Healthcare […]
Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity
PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain to treat resistant/difficult to treat hypertension and heart-failure, today published its first half 2022 results. Jean-Philippe Milon, CEO […]
Starlight Cardiovascular Secures $9.48M in Series A Financing to Advance Pediatric Health
SAN DIEGO, Oct. 4, 2022 /PRNewswire/ — Starlight Cardiovascular announced today that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress development of its portfolio of pediatric interventional cardiology devices. The financing is led by Bird B and included conversion of previously-issued notes. “Congenital Heart Defects are […]
Centerline Biomedical announces Gulam Khan as Chief Executive Officer
CLEVELAND, Oct. 4, 2022 /PRNewswire/ — Centerline Biomedical, Inc. (“Centerline”), which recently commercialized its Intra-Operative Positioning Systems IOPS®, has appointed Gulam Khan, Chief Executive Officer. Mr. Khan has more than two decades of executive leadership experience, including serving as the President and CEO of Mentor, Ohio-based US Endoscopy and serving as the Senior Vice […]
Shady Grove Medical Center Earns Certification in Breakthrough Stroke Treatment from The Joint Commission
ROCKVILLE, Md., Oct. 4, 2022 /PRNewswire/ — Adventist HealthCare Shady Grove Medical Center has earned national certification for mechanical thrombectomy, a minimally invasive surgical treatment for stroke that studies show can improve outcomes for many patients. Shady Grove Medical Center attained Thrombectomy-Capable Stroke Center (TSC) Certification from The Joint Commission, in collaboration with the […]
Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment
Award-Winning Interventional Radiologist in the NY Metro Area Adds Significant Depth and Experience HINGHAM, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), which continues to be committed to expanding its capabilities, today announced the newest appointment to its Scientific Advisory Board (SAB), David C. Madoff, M.D. […]
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on October 1, 2022 that were approved by the Compensation Committee of its Board of […]
InCarda Therapeutics Announces Execution of Planned CEO Transition to Drive Next Phase of Corporate Growth
Robert Lisicki Appointed as New Chief Executive Officer and Board Member; Possesses Broad Commercial and Public Company Experience Grace E, Colón, Ph.D., Stepping Aside Following Nearly Ten Years as President and CEO; Will Serve as Consultant to Ensure Smooth Leadership Transition SAN FRANCISCO, Oct. 04, 2022 (GLOBE NEWSWIRE) — InCarda […]
Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting
Traditional Care: More than 50% Discharged From Hospital With Suboptimal Treatment Oak Ridge, TN, Oct. 04, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces new data from the Mayo Clinic in Rochester, NY validating the benefits of the Company’s BVA-100 blood test for patients with […]



